Overcoming Barriers to Initiating or Intensifying Insulin Therapy: Best Practices for the Family Physician Webcast Evaluation (ID: i718a) Survey

Question Title

* 1. How many patients with diabetes do you manage in your practice per week?

Question Title

* 2. Which of the following best describes the impact of this activity on your performance?

I gained new strategies/skills/information that I can apply to my area of practice.

I need more information before I change my practice behavior.

This activity will not change my practice, as my current practice is consistent with the information presented.

This activity will not change my practice, as I do not agree with the information presented.

Question Title

* 3. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 4. How committed are you to making changes in your practice based on your participation in this activity?

Very committed

Committed

Neutral

Not committed

I do not plan to make changes.

Question Title

* 5. What barriers do you see to making changes in your practice?

Question Title

* 6. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities:

Question Title

* 7. After participating in today’s activity, I am now able to:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Articulate clinical strategies for the timely initiation and modification, and intensification of insulin therapy to achieve glycemic control	Articulate clinical strategies for the timely initiation and modification, and intensification of insulin therapy to achieve glycemic control Strongly agree	Articulate clinical strategies for the timely initiation and modification, and intensification of insulin therapy to achieve glycemic control Agree	Articulate clinical strategies for the timely initiation and modification, and intensification of insulin therapy to achieve glycemic control Neutral	Articulate clinical strategies for the timely initiation and modification, and intensification of insulin therapy to achieve glycemic control Disagree	Articulate clinical strategies for the timely initiation and modification, and intensification of insulin therapy to achieve glycemic control Strongly disagree
Explain novel strategies to optimize insulin therapy in clinical practice to improve glucose control, reduce risk of weight gain and hypoglycemia, and increase patient access, acceptance and adherence	Explain novel strategies to optimize insulin therapy in clinical practice to improve glucose control, reduce risk of weight gain and hypoglycemia, and increase patient access, acceptance and adherence Strongly agree	Explain novel strategies to optimize insulin therapy in clinical practice to improve glucose control, reduce risk of weight gain and hypoglycemia, and increase patient access, acceptance and adherence Agree	Explain novel strategies to optimize insulin therapy in clinical practice to improve glucose control, reduce risk of weight gain and hypoglycemia, and increase patient access, acceptance and adherence Neutral	Explain novel strategies to optimize insulin therapy in clinical practice to improve glucose control, reduce risk of weight gain and hypoglycemia, and increase patient access, acceptance and adherence Disagree	Explain novel strategies to optimize insulin therapy in clinical practice to improve glucose control, reduce risk of weight gain and hypoglycemia, and increase patient access, acceptance and adherence Strongly disagree
Utilize a patient-centered approach to individualize therapy and appropriately and effectively transition patients to insulin and insulin combinations	Utilize a patient-centered approach to individualize therapy and appropriately and effectively transition patients to insulin and insulin combinations Strongly agree	Utilize a patient-centered approach to individualize therapy and appropriately and effectively transition patients to insulin and insulin combinations Agree	Utilize a patient-centered approach to individualize therapy and appropriately and effectively transition patients to insulin and insulin combinations Neutral	Utilize a patient-centered approach to individualize therapy and appropriately and effectively transition patients to insulin and insulin combinations Disagree	Utilize a patient-centered approach to individualize therapy and appropriately and effectively transition patients to insulin and insulin combinations Strongly disagree

Question Title

* 8. Davida F. Kruger, MSN, APN-BC, BC-ADM, effectively:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Presented the material	Presented the material Strongly agree	Presented the material Agree	Presented the material Neutral	Presented the material Disagree	Presented the material Strongly disagree
Avoided commercial bias	Avoided commercial bias Strongly agree	Avoided commercial bias Agree	Avoided commercial bias Neutral	Avoided commercial bias Disagree	Avoided commercial bias Strongly disagree

Question Title

* 9. The content presented:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Enhanced my current knowledge base	Enhanced my current knowledge base Strongly agree	Enhanced my current knowledge base Agree	Enhanced my current knowledge base Neutral	Enhanced my current knowledge base Disagree	Enhanced my current knowledge base Strongly disagree
Addressed my most pressing questions	Addressed my most pressing questions Strongly agree	Addressed my most pressing questions Agree	Addressed my most pressing questions Neutral	Addressed my most pressing questions Disagree	Addressed my most pressing questions Strongly disagree
Promoted improvements or quality in health care	Promoted improvements or quality in health care Strongly agree	Promoted improvements or quality in health care Agree	Promoted improvements or quality in health care Neutral	Promoted improvements or quality in health care Disagree	Promoted improvements or quality in health care Strongly disagree
Was scientifically rigorous and evidence based	Was scientifically rigorous and evidence based Strongly agree	Was scientifically rigorous and evidence based Agree	Was scientifically rigorous and evidence based Neutral	Was scientifically rigorous and evidence based Disagree	Was scientifically rigorous and evidence based Strongly disagree
Avoided commercial bias or influence	Avoided commercial bias or influence Strongly agree	Avoided commercial bias or influence Agree	Avoided commercial bias or influence Neutral	Avoided commercial bias or influence Disagree	Avoided commercial bias or influence Strongly disagree

Question Title

* 10. If you indicated that you perceived commercial bias or influence, please describe:

Question Title

* 11. What are the most important topics/issues surrounding Diabetes management that still needs to be addressed or advanced with continued CME programs?

Question Title

* 12. How would you rate the format of this activity?

Excellent

Average

Below average

Poor

Question Title

* 13. Would you be willing to participate in a postactivity follow-up survey?

Yes